fluid and electrolyte imbalance - Nursing Case Study

Pathophysiology

• Primary mechanism: Disruption in sodium regulation, often due to renal dysfunction, leads to altered osmotic gradients, causing water retention or loss, and impacting cellular function and volume status critically in severe cases.

• Secondary mechanism: Impaired aldosterone or antidiuretic hormone (ADH) secretion, as seen in conditions like Addison's disease or SIADH, disrupts fluid balance by affecting renal absorption of water and electrolytes, exacerbating volume overload or depletion.

• Key complication: Severe electrolyte imbalances, such as hyperkalemia or hyponatremia, can precipitate life-threatening cardiac arrhythmias or neurological disturbances, highlighting the critical need for timely diagnosis and intervention in acute care settings.

Patient Profile

Demographics:

58-year-old male, construction worker

History:

• Key past medical history: Chronic kidney disease, hypertension, type 2 diabetes mellitus

• Current medications: Lisinopril, Metformin, Furosemide, Insulin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe fatigue and muscle weakness

• Key symptoms: Persistent nausea, confusion, decreased urine output, shortness of breath

• Vital signs: Blood pressure 92/58 mmHg, heart rate 128 bpm, respiratory rate 30 breaths per minute, temperature 101.4°F, oxygen saturation 88% on room air

Section 1

Initial Assessment Findings:

Upon arrival at the emergency department, the patient's condition was further evaluated. The initial assessment revealed significant jugular venous distension and peripheral edema, indicating fluid overload despite the patient's report of decreased urine output. Auscultation of the lungs revealed bilateral crackles, suggesting pulmonary congestion. Neurological assessment showed the patient was disoriented to time and place, with a Glasgow Coma Scale score of 13, indicating mild confusion, which may be attributed to electrolyte imbalances or uremic encephalopathy given his chronic kidney disease.

Laboratory tests were promptly ordered to assess the extent of the electrolyte disturbances. Initial laboratory results showed a serum potassium level of 6.8 mEq/L, indicative of severe hyperkalemia, which poses an immediate risk of cardiac arrhythmias. The sodium level was critically low at 122 mEq/L, confirming hyponatremia, which can exacerbate the patient's neurological symptoms. Blood urea nitrogen (BUN) and creatinine levels were markedly elevated, reflecting acute exacerbation of renal dysfunction. Arterial blood gas analysis showed metabolic acidosis with a pH of 7.28 and an elevated anion gap, further complicating the patient's clinical picture.

These findings necessitated urgent interventions to stabilize the patient's condition. Management included immediate administration of calcium gluconate to protect the heart from the effects of hyperkalemia, along with insulin and glucose to facilitate intracellular shifting of potassium. Concurrently, hypertonic saline infusion was considered to cautiously correct the hyponatremia. Continuous cardiac monitoring was initiated due to the high risk of arrhythmias, and hemodialysis was discussed as a potential definitive treatment for both the hyperkalemia and fluid overload, taking into account the patient's chronic kidney disease and deteriorating renal function. As the clinical team prepared for these interventions, the patient's status remained critical, with ongoing monitoring required to assess response to treatment and prevent further complications.

Section 2

Response to Interventions:

As the medical team implemented the initial interventions, the patient's condition underwent subtle but significant changes. The administration of calcium gluconate successfully provided temporary cardiac membrane stabilization, with continuous cardiac monitoring showing a reduction in the frequency of premature ventricular contractions. Insulin and glucose therapy facilitated the intracellular shift of potassium, evidenced by a drop in serum potassium levels to 5.9 mEq/L within the first hour. However, despite these improvements, the patient’s respiratory status began to deteriorate, with increased work of breathing and a respiratory rate climbing to 28 breaths per minute. Oxygen saturation dropped to 88% on room air, necessitating supplemental oxygen via a non-rebreather mask to maintain adequate oxygenation.

Despite cautious administration of hypertonic saline, the patient's neurological status showed minimal improvement. The sodium level increased slowly to 124 mEq/L, but the patient remained disoriented, with a Glasgow Coma Scale score remaining at 13. Additionally, serial arterial blood gas analyses revealed persistent metabolic acidosis, with a slight improvement in pH to 7.30 but continued elevation of the anion gap. Given these findings, the team recognized the critical need for renal replacement therapy to address the underlying accumulation of uremic toxins and to more effectively manage the fluid overload and electrolyte disturbances.

As preparations for emergent hemodialysis were underway, the patient's blood pressure became increasingly labile, fluctuating between hypertensive episodes of 180/100 mmHg and hypotensive readings as low as 90/60 mmHg. These fluctuations complicated fluid management and posed a risk for further organ perfusion compromise. The clinical team had to consider the possibility of autonomic instability or additional underlying endocrine derangements, such as adrenal insufficiency, which could be contributing to the erratic hemodynamics. This necessitated a comprehensive reassessment and expansion of the diagnostic workup to prevent the emergence of further complications and ensure stabilization before, during, and after hemodialysis.

Section 3

As the team prepared for hemodialysis, a new set of diagnostic results provided critical insights into the patient's evolving condition. The latest serum electrolyte panel revealed an unexpected development: an acute drop in calcium levels to 7.2 mg/dL, likely exacerbating the patient's neuromuscular irritability and contributing to the persistent disorientation. Concurrently, a cortisol stimulation test was conducted to rule out adrenal insufficiency, revealing suboptimal cortisol levels post-administration, suggestive of a potential adrenal crisis. These findings necessitated immediate intervention with intravenous calcium supplementation and stress-dose corticosteroids to stabilize the patient before initiating hemodialysis.

In addition to the biochemical abnormalities, imaging studies were performed to further elucidate the underlying causes of the patient's respiratory deterioration. A portable chest X-ray indicated the presence of bilateral infiltrates, raising suspicion for pulmonary edema secondary to fluid overload, compounded by the patient's existing metabolic acidosis. This discovery prompted the initiation of non-invasive positive pressure ventilation to improve alveolar recruitment and gas exchange, while diuretics were cautiously administered to mitigate fluid accumulation without exacerbating the patient's labile blood pressure.

These developments underscored the complexity of the patient's condition, requiring the clinical team to re-evaluate and adjust their therapeutic strategies continuously. The integration of these new diagnostic findings into the patient's management plan highlighted the importance of a dynamic, interdisciplinary approach to care. As the team prepared to proceed with hemodialysis, they remained vigilant for potential hemodynamic instability and the need for rapid intervention to prevent further complications. This phase of the patient's journey set the stage for intensive monitoring and adaptive clinical decision-making to navigate the intricacies of this multifaceted case.

Section 4

As the team closely monitored the patient's response to the interventions, a change in status became evident, necessitating further clinical scrutiny. Despite the administration of intravenous calcium gluconate, the patient's neuromuscular irritability persisted, manifesting as intermittent tetany and a positive Chvostek's sign, suggesting that the hypocalcemia was more profound than initially anticipated. Concurrently, the patient's mental status fluctuated, with episodes of confusion and lethargy, raising concerns about potential cerebral edema or worsening metabolic derangement. Vital signs indicated a fluctuating blood pressure, with systolic readings ranging from 85 to 100 mmHg, and heart rate oscillating between 110 to 130 beats per minute, indicative of compensatory tachycardia.

The interdisciplinary team decided to conduct a rapid reassessment and ordered additional lab tests, including an ionized calcium level, which returned critically low at 0.95 mmol/L, confirming the severity of hypocalcemia. They also reviewed the patient's arterial blood gas results, which showed a pH of 7.28, pCO2 of 32 mmHg, and HCO3 of 15 mEq/L, indicating persistent metabolic acidosis with partial respiratory compensation. The urine output decreased to 15 mL/hr, raising alarms for acute kidney injury exacerbated by the underlying fluid and electrolyte imbalance. The team intensified their efforts, adjusting the calcium infusion rate and optimizing corticosteroid therapy, while closely monitoring the patient's hemodynamics and mental status.

As the patient's condition teetered on the edge of stability, the team remained vigilant, anticipating potential complications such as cardiac arrhythmias or seizures due to the critical electrolyte disturbances. The decision to initiate hemodialysis was revisited, weighing the risks of hemodynamic instability against the necessity of correcting the severe biochemical imbalances. The scenario underscored the necessity for precision in clinical judgment and the readiness to adapt therapeutic strategies in response to the evolving clinical picture, setting the stage for the next critical phase in the patient's management.

Section 5

As the team continued to monitor the patient closely, a sudden change in status warranted immediate attention. The patient exhibited a marked increase in neuromuscular irritability, progressing to generalized muscle spasms and eventually a tonic-clonic seizure, despite ongoing calcium gluconate therapy. This alarming development suggested a critical tipping point in the patient's electrolyte disturbance and raised concerns about an impending neurological crisis. Vital signs showed further deterioration, with the heart rate spiking to 140 beats per minute and blood pressure dropping to 80/50 mmHg, indicating worsening hemodynamic instability. Central venous pressure measurements revealed a drop to 2 mmHg, suggesting intravascular volume depletion and potential hypovolemic shock.

Additional diagnostic results from a hastily ordered EEG confirmed diffuse cerebral activity changes consistent with severe electrolyte imbalance, while a CT scan ruled out acute intracranial pathology but hinted at subtle signs of cerebral edema. The team observed a concerning trend of rising serum potassium levels, now at 6.2 mEq/L, likely due to the acute renal impairment and resultant decreased excretion, further complicating the electrolyte profile and increasing the risk of life-threatening arrhythmias.

In response to these new complications, the interdisciplinary team urgently recalibrated their management plan. The decision was made to initiate continuous renal replacement therapy (CRRT) to address the multifaceted electrolyte imbalances and prevent further cerebral and cardiovascular complications. Concurrently, intravenous fluid resuscitation with isotonic saline was intensified to support hemodynamic stability and optimize renal perfusion. The team also adjusted the patient's medication regimen to include anti-seizure medication, and discussions were initiated with the neurology team for ongoing management. This pivotal moment underscored the critical importance of dynamic clinical reasoning and the need for an agile therapeutic approach as the patient's condition continued to evolve.